Ebola Crisis of 2014: Are Current Strategies Enough to Meet the Long-Run Challenges Ahead?
- 1 May 2015
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 105 (5) , e8-e10
Abstract
The outbreak of the Ebola virus disease (EVD) in 2014 mobilized international efforts to contain a global health crisis. The emergence of the deadly virus in the United States and Europe among health care workers intensified fears of a worldwide epidemic. Market incentives for pharmaceutical firms to allocate their research and development resources toward Ebola treatments were weak because the limited number of EVD cases were previously confined to rural areas of West Africa. We discuss 3 policy recommendations to address the long-term challenges of EVD in an interconnected world.Keywords
This publication has 7 references indexed in Scilit:
- Ebola virus disease: a highly fatal infectious disease reemerging in West AfricaMicrobes and Infection, 2015
- Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward ProjectionsNew England Journal of Medicine, 2014
- The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?Health Policy, 2010
- Market incentives and pharmaceutical innovationJournal of Health Economics, 2008
- Advance market commitments for vaccines against neglected diseases: estimating costs and effectivenessHealth Economics, 2006
- Fruit bats as reservoirs of Ebola virusNature, 2005
- Ebola Viruses2003